Darzalex 400mg/20ml injection
Darzalex 400mg/20ml Injection (Daratumumab) is a monoclonal antibody medication used in the treatment of multiple myeloma, a type of blood cancer. It targets the CD38 protein found on the surface of myeloma cells, helping the immune system destroy these malignant cells. Doctors often prescribe Darzalex as part of a combination therapy with other cancer treatments, such as proteasome inhibitors or immunomodulatory drugs.
Each vial contains 400mg of Daratumumab in 20ml solution, designed for intravenous infusion. This medication is administered in a hospital or clinical setting by healthcare professionals. Darzalex provides a targeted therapy option for patients with relapsed or refractory multiple myeloma, especially those who have not responded to other treatments.
Before starting therapy, your doctor will evaluate your overall health, blood counts, and liver function to determine the right treatment plan. You will also receive pre-infusion medications to reduce the risk of infusion-related reactions.
Store Darzalex vials in a refrigerator between 2°C and 8°C. Do not freeze or shake the vials. Always protect the medication from light and keep it out of children’s reach.
Darzalex 400mg/20ml Injection (Daratumumab) is a breakthrough immunotherapy used in the management of multiple myeloma, a form of cancer that affects plasma cells in the bone marrow. Daratumumab is a monoclonal antibody that binds to the CD38 protein on myeloma cells, triggering the immune system to attack and eliminate these cancerous cells.
Doctors prescribe Darzalex for patients with relapsed or refractory multiple myeloma who have failed to respond to prior treatments. It is also used in combination with other therapies such as lenalidomide, bortezomib, or dexamethasone to improve treatment outcomes. Darzalex has shown significant effectiveness in extending progression-free survival in multiple myeloma patients.
Each single-use vial contains 400mg of Daratumumab in 20ml of solution. The medication is administered via intravenous infusion under strict medical supervision. The infusion process requires premedication with corticosteroids, antipyretics, and antihistamines to minimize infusion-related side effects like fever, chills, or allergic reactions.
Your healthcare provider will determine the appropriate dosing schedule based on your treatment regimen. Typically, the infusion is given weekly for the initial cycles, followed by bi-weekly or monthly administration as maintenance therapy.
Store Darzalex in a refrigerator at 2°C to 8°C. Protect the vial from light, and do not freeze or shake it. Ensure it stays out of children’s reach.
For more information on cancer care medicines, explore our Medicine Category. You can also find other essential healthcare products in our online pharmacy shop.
Related products
